event,time
85 years old , 0\
    male , 0\
    type 2 diabetes mellitus , 0\
    hypertension , 0\
    furosemide , 0\
    hydralazine , 0\
    β-blocker , 0\
    dyslipidemia , 0\
    iron deficiency anemia , 0\
    ferrous sulphate , 0\
    chronic kidney disease , 0\
    dementia , 0\
    reduced oral intake , -168\
    recurrent vomiting , -168\
    decreased level of consciousness , -168\
    severely dehydrated , 0\
    hypotensive (92/58) , 0\
    mildly tachypneic (20) , 0\
    heart rate of 87 , 0\
    Glasgow coma scale of 11 , 0\
    melena , 0\
    leukocytosis (12 × 10^9) , 0\
    low hemoglobin (12.3 g/dL) , 0\
    high C-reactive protein (106 mg/L) , 0\
    high urea (53 mmol/L) , 0\
    acute kidney injury , 0\
    chronic kidney disease , 0\
    elevated lactate (4.6 mmol/L) , 0\
    elevated procalcitonin (4.88 ng/mL) , 0\
    urinary tract infection , 0\
    admitted to intensive care unit , 0\
    severe sepsis , 0\
    secondary to urinary tract infection , 0\
    acute on top of chronic kidney injury , 0\
    upper gastrointestinal bleeding , 0\
    hemoglobin dropped to 9.7 g/dL , 48\
    hiatus hernia , 0\
    Hill's classification grade 4 , 0\
    7-mm sessile polyp , 0\
    Paris classification 0-Is , 0\
    polyp removed by snaring , 0\
    extensive gray to black speckles on gastric corpus , 0\
    duodenal pseudomelanosis , 0\
    gastric pseudomelanosis , 0\
    intact lining epithelium , 0\
    preserved architecture , 0\
    brownish-black pigment-laden macrophages , 0\
    Perl's Prussian blue stain positive , 0\
    iron deposition confirmed , 0\
    pseudomelanosis diagnosis , 0\
    duodenal polyp hyperplastic , 0\
    urosepsis managed with antibiotics , 0\
    kidney injury managed conservatively , 0\
    intravenous fluids , 0\
    supportive measures , 0\
    clinical improvement , 120\
    transferred to wards , 120\
    renal function back to baseline , 288\
    septic markers improved , 288\
    discharged home , 288\
    full recovery , 288\
    melena , 0\
    drop in hemoglobin , 48\
    esophagogastroduodenoscopy , 0\
    pseudomelanosis incidental finding , 0\
    no relation to upper gastrointestinal bleeding , 0\
    no long-term sequelae , 0\
    clinically insignificant , 0\
    charcoal ingestion , 0\
    ferrous sulfide , 0\
    hemosiderin , 0\
    lipofuscin , 0\
    pseudomelanin deposition , 0\
    calcium deposition , 0\
    magnesium deposition , 0\
    differential diagnosis excluded , 0\
    malignant melanoma excluded , 0\
    brown bowel syndrome excluded , 0\
    hemosiderosis excluded , 0\
    hemochromatosis excluded , 0\
    Masson-Fontana stain not done , 0\
    ethical approval obtained , 0\
    no conflict of interest , 0\
    no funding received , 0\
    case report drafted , 0\
    literature review , 0\
    critical revision , 0\
    editing , 0\
    final approval , 0\
    data available , 0\
    histopathology images provided , 0\
    figures included , 0\
    table included , 0\
    informed consent obtained , 0\
    IRB approval , 0\
    references cited , 0\
    authors acknowledged , 0\
    figures descriptions provided , 0\
    differential diagnosis table , 0\
    differential diagnosis characteristics , 0\
    organs involved , 0\
    histopathology findings , 0\
    metastatic melanoma , 0\
    gastric siderosis , 0\
    brown bowel syndrome , 0\
    melanosis coli , 0\
    chronic constipation , 0\
    laxatives use , 0\
    dark mucosal staining , 0\
    malignant melanoma , 0\
    hemosiderosis , 0\
    hemochromatosis , 0\
    iron supplementation , 0\
    vitamin E deficiency , 0\
    malabsorption syndromes , 0\
    celiac disease , 0\
    Crohn's disease , 0\
    post-gastric bypass , 0\
    alcohol abuse , 0\
    lipofuscin-like pigment deposits , 0\
    smooth muscle cells , 0\
    muscularis mucosa , 0\
    muscularis propria , 0\
    cytological atypia , 0\
    increased nuclear cytoplasmic ratio , 0\
    enlarged hyperchromic nuclei , 0\
    prominent nucleoli , 0\
    frequent mitoses , 0\
    immunohistochemical stains , 0\
    Melan-A , 0\
    S100 , 0\
    HMB45 , 0\
    SOX-10 , 0\
    yellow-brown hemosiderin , 0\
    stains positive for iron , 0\
    alcohol-related liver disease , 0\
    repeated blood transfusion , 0\
    primary skin melanoma , 0\
    multiple flat or polypoid lesions , 0\
    GI tract involvement , 0\
    dark-blackish discoloration , 0\
    primary condition identified , 0\
    detailed history taken , 0\
    vitamin E deficiency , 0\
    alcohol abuse , 0\
    chronic constipation , 0\
    long-term laxatives use , 0\
    melanosis coli , 0\
    benign condition , 0\
    histopathological examination , 0\
    confirmation of diagnosis , 0\
    exclusion of metastatic melanoma , 0\
    incidental finding , 0\
    critically ill , 0\
    upper gastrointestinal bleeding , 0\
    melena , 0\
    hemoglobin drop , 48\
    sepsis managed , 0\
    culture-guided antibiotics , 0\
    conservative management , 0\
    intravenous fluids , 0\
    supportive measures , 0\
    clinical improvement , 120\
    transfer to wards , 120\
    renal function recovery , 288\
    septic markers improvement , 288\
    discharge after 12 days , 288\
    full recovery , 288\
    pseudomelanosis linked to chronic kidney disease , 0\
    diabetes mellitus , 0\
    hypertension , 0\
    ferrous sulphate , 0\
    hydralazine , 0\
    furosemide , 0\
    β-blockers , 0\
    rare endoscopic finding , 0\
    speckled dark pigmentations , 0\
    lamina propria macrophages , 0\
    iron deposition , 0\
    Prussian blue stain , 0\
    hyperplastic polyp , 0\
    snaring removal , 0\
    sessile polyp , 0\
    Paris classification , 0\
    Hill's classification , 0\
    hiatus hernia , 0\
    gastric corpus , 0\
    duodenum , 0\
    gastric mucosa , 0\
    preserved architecture , 0\
    brownish-black pigment , 0\
    macrophages , 0\
    Perl's stain , 0\
    positive iron , 0\
    pseudomelanosis confirmed , 0\
    differential diagnosis , 0\
    excluded malignancies , 0\
    benign nature confirmed , 0\
    no specific etiology , 0\
    contributing factors , 0\
    medications , 0\
    comorbidities , 0\
    incidental findings , 0\
    no long-term effects , 0\
    clinically insignificant , 0\
    histopathology confirmation , 0\
    exclusion of melanoma , 0\
    iron supplements , 0\
    propranolol , 0\
    hydrochlorothiazide , 0\
    hemochromatosis , 0\
    gastrointestinal bleeding , 0\
    chronic kidney disease , 0\
    diabetes mellitus , 0\
    hypertension , 0\
    medications list , 0\
    ferrous sulphate , 0\
    hydralazine , 0\
    furosemide , 0\
    β-blockers , 0\
    chronic conditions , 0\
    dementia follow-up , 0\
    acute presentation , 0\
    dehydration , 0\
    hypotension , 0\
    tachypnea , 0\
    heart rate , 0\
    Glasgow coma scale , 0\
    laboratory abnormalities , 0\
    leukocytosis , 0\
    hemoglobin , 0\
    CRP , 0\
    urea , 0\
    AKI , 0\
    CKD , 0\
    lactate , 0\
    procalcitonin , 0\
    urine analysis , 0\
    UTI , 0\
    ICU admission , 0\
    sepsis diagnosis , 0\
    UTI source , 0\
    AKI on CKD , 0\
    upper GI bleeding , 0\
    hemoglobin drop day 2 , 48\
    EGD findings , 0\
    histology results , 0\
    iron deposition confirmed , 0\
    management steps , 0\
    antibiotics , 0\
    fluids , 0\
    supportive care , 0\
    transfer to wards day 5 , 120\
    renal recovery , 288\
    sepsis resolution , 288\
    discharge day 12 , 288\
    recovery achieved , 288\
    pseudomelanosis characteristics , 0\
    endoscopic features , 0\
    pigment deposition , 0\
    iron in macrophages , 0\
    other minerals , 0\
    differential diagnoses , 0\
    exclusion process , 0\
    ethical considerations , 0\
    consent obtained , 0\
    IRB approval , 0\
    no conflicts , 0\
    funding sources , 0\
    author contributions , 0\
    data availability , 0\
    acknowledgments , 0\
    figures included , 0\
    table included , 0\
    references cited , 0\
    case report details , 0\
    patient demographics , 0\
    clinical course , 0\
    management outcomes , 0\
    pseudomelanosis discussion , 0\
    differential diagnosis table , 0\
    histopathology images , 0\
    stain results , 0\
    endoscopic images , 0\
    polyp removal , 0\
    sepsis management , 0\
    kidney injury management , 0\
    discharge outcome , 0\
    full recovery confirmed , 288\
    pseudomelanosis incidental , 0\
    no relation to GI bleeding , 0\
    benign nature , 0\
    histopathology needed , 0\
    melanoma excluded , 0\
    iron confirmed , 0\
    Prussian blue positive , 0\
    hemosiderin excluded , 0\
    lipofuscin excluded , 0\
    pseudomelanin excluded , 0\
    mineral deposits , 0\
    calcium , 0\
    magnesium , 0\
    differentials excluded , 0\
    melanoma features , 0\
    siderosis features , 0\
    brown bowel features , 0\
    hemosiderosis features , 0\
    hemochromatosis features , 0\
    Masson-Fontana not used , 0\
    immunohistochemical markers , 0\
    melanoma stains , 0\
    siderosis stains , 0\
    brown bowel features , 0\
    clinical insignificance , 0\
    no sequelae , 0\
    incidental finding , 0\
    critical illness , 0\
    upper GI bleed , 0\
    melena present , 0\
    hemoglobin drop , 48\
    EGD performed , 0\
    pseudomelanosis found , 0\
    management successful , 0\
    recovery achieved , 288\
    patient demographics , 0\
    comorbidities listed , 0\
    medications listed , 0\
    acute symptoms , 0\
    examination findings , 0\
    lab results , 0\
    diagnosis made , 0\
    ICU admission , 0\
    treatment given , 0\
    procedures done , 0\
    histopathology results , 0\
    management steps , 0\
    outcome described , 0\
    discussion points , 0\
    ethics statement , 0\
    conflicts statement , 0\
    funding statement , 0\
    author contributions , 0\
    data statement , 0\
    acknowledgments , 0\
    figures and tables , 0\
    references , 0\
    patient age , 0\
    patient sex , 0\
    presenting symptoms , 0\
    examination signs , 0\
    lab tests , 0\
    imaging , 0\
    endoscopic findings , 0\
    histology , 0\
    stains used , 0\
    diagnosis confirmation , 0\
    treatment administered , 0\
    response to treatment , 0\
    discharge status , 0\
    follow-up , 0\
    case rarity , 0\
    literature review , 0\
    differentials discussed , 0\
    management approach , 0\
    patient outcome , 0\
    ethical compliance , 0\
    author roles , 0\
    data sharing , 0\
    acknowledgments made , 0\
    figures description , 0\
    table description , 0\
    references cited , 0\
    patient history , 0\
    chronic conditions , 0\
    acute conditions , 0\
    diagnostic process , 0\
    therapeutic interventions , 0\
    clinical course , 0\
    recovery timeline , 0\
    pseudomelanosis features , 0\
    histopathological confirmation , 0\
    differential exclusion , 0\
    management details , 0\
    outcome details , 0\
    ethics details , 0\
    conflict details , 0\
    funding details , 0\
    author details , 0\
    data details , 0\
    acknowledgment details , 0\
    figure details , 0\
    table details , 0\
    reference details , 0\
    pseudomelanosis duodeni , 0\
    gastric pseudomelanosis , 0\
    duodenal pseudomelanosis , 0\
    endoscopic findings , 0\
    histology findings , 0\
    iron deposition , 0\
    pigment-laden macrophages , 0\
    Prussian blue positivity , 0\
    hyperplastic polyp , 0\
    sessile polyp , 0\
    snare removal , 0\
    Hill's classification , 0\
    Paris classification , 0\
    hiatus hernia , 0\
    gastric corpus , 0\
    duodenum , 0\
    ICU stay , 0\
    ward transfer , 0\
    discharge day 12 , 288\
    full recovery , 288\
    pseudomelanosis incidental , 0\
    upper GI bleeding , 0\
    melena , 0\
    hemoglobin drop , 48\
    sepsis management , 0\
    antibiotics , 0\
    fluids , 0\
    supportive care , 0\
    renal recovery , 288\
    septic recovery , 288\
    discharge home , 288\
    pseudomelanosis factors , 0\
    chronic kidney disease , 0\
    diabetes mellitus , 0\
    hypertension , 0\
    medications , 0\
    ferrous sulphate , 0\
    hydralazine , 0\
    furosemide , 0\
    β-blockers , 0\
    rare condition , 0\
    benign nature , 0\
    histopathology needed , 0\
    melanoma excluded , 0\
    iron confirmed , 0\
    management successful , 0\
    patient recovered , 288\
    case reported , 0\
    ethics obtained , 0\
    no conflicts , 0\
    no funding , 0\
    authors involved , 0\
    data available , 0\
    pathologist acknowledged , 0\
    figures provided , 0\
    table included , 0\
    references cited , 0\
    pseudomelanosis duodeni , 0\
    gastric pseudomelanosis , 0\
    endoscopic appearance , 0\
    histology confirmation , 0\
    management approach , 0\
    patient outcome , 0\
    ethical compliance , 0\
    author contributions , 0\
    data sharing , 0\
    acknowledgments , 0\
    figures and tables , 0\
    references , 0
